173 related articles for article (PubMed ID: 8074820)
1. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense?
de Visscher AV; Manni JJ
Arch Otolaryngol Head Neck Surg; 1994 Sep; 120(9):934-9. PubMed ID: 8074820
[TBL] [Abstract][Full Text] [Related]
2. [Consumption and value of regular after care by patients with squamous cell carcinomas of the larynx, mouth cavity and pharynx].
Wolfensberger M
HNO; 1988 Jan; 36(1):28-32. PubMed ID: 2832353
[TBL] [Abstract][Full Text] [Related]
3. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
4. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue.
Merkx MA; van Gulick JJ; Marres HA; Kaanders JH; Bruaset I; Verbeek A; de Wilde PC
Head Neck; 2006 Jan; 28(1):1-7. PubMed ID: 16155911
[TBL] [Abstract][Full Text] [Related]
6. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
Esser D; Anke S; Roessner A; Freigang B
Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
[TBL] [Abstract][Full Text] [Related]
7. Analysis of treatment results for floor-of-mouth cancer.
Sessions DG; Spector GJ; Lenox J; Parriott S; Haughey B; Chao C; Marks J; Perez C
Laryngoscope; 2000 Oct; 110(10 Pt 1):1764-72. PubMed ID: 11037841
[TBL] [Abstract][Full Text] [Related]
8. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
9. [Malignancies of the mouth cavity, pharynx and larynx--symptoms, diagnosis and therapy].
Zbären P
Ther Umsch; 1998 Jul; 55(7):449-52. PubMed ID: 9702117
[TBL] [Abstract][Full Text] [Related]
10. Changing patterns of failure of head and neck cancer.
Taneja C; Allen H; Koness RJ; Radie-Keane K; Wanebo HJ
Arch Otolaryngol Head Neck Surg; 2002 Mar; 128(3):324-7. PubMed ID: 11886352
[TBL] [Abstract][Full Text] [Related]
11. Second malignant neoplasms in patients with head and neck squamous cell carcinomas.
Boysen M; Loven JO
Acta Oncol; 1993; 32(3):283-8. PubMed ID: 8323766
[TBL] [Abstract][Full Text] [Related]
12. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
Matoscevic K; Graf N; Pezier TF; Huber GF
Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
[TBL] [Abstract][Full Text] [Related]
13. Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer.
Brands MT; Smeekens EAJ; Takes RP; Kaanders JHAM; Verbeek ALM; Merkx MAW; Geurts SME
Cancer Med; 2019 Sep; 8(12):5810-5819. PubMed ID: 31400079
[TBL] [Abstract][Full Text] [Related]
14. Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature.
Brands MT; Brennan PA; Verbeek ALM; Merkx MAW; Geurts SME
Eur J Surg Oncol; 2018 May; 44(5):559-565. PubMed ID: 29433990
[TBL] [Abstract][Full Text] [Related]
15. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
[TBL] [Abstract][Full Text] [Related]
16. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
17. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
18. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
19. Value of routine follow-up for recurrence detection after treatment with curative intent for laryngeal squamous cell carcinoma.
van de Weerd C; Geurts SME; Vercoulen RJMT; van Veggel IHF; Brands MT; Marres HAM; Hermens RPMG; van Tol-Geerdink JJ; Kaanders JHAM; Takes RP
Eur J Surg Oncol; 2024 Jan; 50(1):107304. PubMed ID: 38043360
[TBL] [Abstract][Full Text] [Related]
20. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
León X; Agüero A; López M; García J; Farré N; López-Pousa A; Quer M
Auris Nasus Larynx; 2015 Apr; 42(2):145-9. PubMed ID: 25459494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]